Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Bitcoin hovers near $64,000 as ETF outflows persist for six weeks. A hawkish Federal Reserve outlook eclipses Iran ce...
When a large investor makes a bold move, the spotlight shifts from fundamentals to signals. This article unpacks how ...
From classroom grades to a billion-dollar chicken brand, Raising Cane’s growth highlights the power—and perils—of a s...
A new tech-specific volatility metric is approaching its highest level in two decades, underscoring rising nerves aro...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
Palo Alto Networks is outperforming Palantir this year, driven by AI-native security demand and margin gains, while i...
A three-way market story unfolds: the Dow climbs, Nasdaq retreats, and SpaceX headlines keep investors guessing. Here...
A widening bottleneck in senior housing is slowing mortgage activity as older homeowners hold equity longer, pressuri...
Ripple-focused ETFs posted another week of net inflows even as XRP struggled to rally. The divergence highlights a sp...
Rising component costs revive a pricing debate for Apple. Analysts weigh whether the company should raise prices on i...
Stepan (SCL) investors are focused on 2025 earnings drivers, margins, and cash flow. This guide breaks down the key c...